Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | PLAU | P00749 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 4/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methane SCHEMBL3560123 | 0.98 | ALDH1A1 (0.57) | ALDH1A1SMN1; SMN2POLBKDM4EPLAU | |
| SCHEMBL18094306 | 0.84 | ALDH1A1 (0.47) | ALDH1A1SMN1; SMN2POLBKDM4EPLAU | |
| SCHEMBL30256557 | 0.84 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2POLBKDM4EPLAU | |
| SCHEMBL24068078 | 0.84 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2POLBKDM4EPLAU | |
| SCHEMBL20350719 | 0.81 | TSHR (0.41) | ALDH1A1SMN1; SMN2POLBKDM4EPLAU | |
| SCHEMBL15181426 | 0.79 | ALDH1A1 (0.39) | ALDH1A1SMN1; SMN2POLBKDM4EPLAU | |
| SCHEMBL120994 | 0.78 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2POLBKDM4EPLAU | |
| SCHEMBL29414916 | 0.78 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2POLBKDM4EPLAU | |
| SCHEMBL30762204 | 0.78 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2POLBKDM4EPLAU | |
| SCHEMBL1716472 | 0.78 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2POLBKDM4EPLAU |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 634 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119264043-A | High-quality fluazinam high-efficiency synthesis process | 吴忠领航生物药业科技有限公司 | 2025-01-07 | — | — | CN | claimed |
| WO-2024259993-A1 | BRAKING ENERGY RECOVERY CONTROL METHOD AND APPARATUS, CONTROL SYSTEM, VEHICLE, AND MEDIUM | 重庆长安汽车股份有限公司 | 2024-12-26 | — | — | WO | claimed |
| CN-118317063-A | Projector control system and control method | 孙晓晨 | 2024-07-09 | — | — | CN | claimed |
| CN-117777129-A | Synthesis method of trifluramide | 利民化学有限责任公司 | 2024-03-29 | — | — | CN | claimed |
| CN-115181060-B | Clean production process for producing 2-amino-3-chloro-5-trifluoromethyl pyridine | 江苏禾裕泰化学有限公司 | 2024-03-19 | — | — | CN | claimed |
| CN-113651718-B | 1, 1-dicyanooxime ether compound and application thereof | 沈阳化工大学 | 2023-10-20 | — | — | CN | claimed |
| CN-113527194-B | Preparation method of 2-amino-3-chloro-5-trifluoromethyl pyridine | 武威广达科技有限公司 | 2023-10-03 | — | — | CN | claimed |
| CN-116552253-A | Braking energy recovery control method, device, control system, vehicle and medium | 重庆长安汽车股份有限公司 | 2023-08-08 | — | — | CN | claimed |
| CN-116308732-A | Integrated algorithm-based overdue prediction method for public accumulation personal loan | 赵作铭 | 2023-06-23 | — | — | CN | claimed |
| CN-115850865-A | Photovoltaic corrosion-resistant anti-aging polypropylene plate and preparation method thereof | 江阴瑞林精密机械制造有限公司 | 2023-03-28 | — | — | CN | claimed |
| CN-101343366-A | Nano-laminal compound with regular array of pyridine and its derivant, and preparation thereof | UNIV SHANGHAI (CN) | 2009-01-14 | — | — | CN | claimed |
| EP-1727799-B1 | NOVEL ALKYL-CONTAINING 5-ACYLINDOLINONES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICAL PRODUCTS | BOEHRINGER INGELHEIM INT (DE) | 2009-01-07 | — | — | EP | claimed |
| US-20050209302-A1 | Alkyl-containing 5-acylindolinones, the preparation thereof and their use as medicaments | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-09-22 | — | — | US | claimed |
| US-5897940-A | Ink jet transparencies | XEROX CORPORATION (US) | 1999-04-27 | — | — | US | claimed |
| EP-0596491-B1 | Method for halogenating an aromatic compound | ISHIHARA SANGYO KAISHA (JP) | 1996-07-10 | — | — | EP | claimed |
| US-5491239-A | Method for halogenating an aromatic compound | ISHIHARA SANGYO KAISHA LTD. (JP) | 1996-02-13 | — | — | US | claimed |
| EP-0596491-A1 | Method for halogenating an aromatic compound | ISHIHARA SANGYO KAISHA, LTD. (JP) | 1994-05-11 | — | — | EP | claimed |
| EP-0031218-B1 | A 2-AMINO-TRIFLUOROMETHYL-HALOGENOPYRIDINE COMPOUND AND A PROCESS FOR PRODUCING THE SAME | ISHIHARA SANGYO KAISHA LTD. (JP) | 1983-05-11 | — | — | EP | claimed |
| US-4349681-A | 2-Amino-3-chloro-5-trifluoromethylpyridine | ISHIHARA SANGYO KAISHA, LTD. (JP) | 1982-09-14 | — | — | US | claimed |
| EP-0031218-A1 | A 2-amino-trifluoromethyl-halogenopyridine compound and a process for producing the same | ISHIHARA SANGYO KAISHA LTD. (JP) | 1981-07-01 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050209302-A1 | Alkyl-containing 5-acylindolinones, the preparation thereof and their use as medicaments | GSK3A, GSK3B, PYGL | ALDH1A1 2722/4885SMN1; SMN2 3715/4885POLB 3759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.